BRIEF-Scynexis receives orphan drug designation for SCY-078 By: Reuters: Company News August 24, 2016 at 09:19 AM EDT * Receives orphan drug designation For SCY-078 for treatment of invasive aspergillus infections Read More >> Related Stocks: Scynexis Inc